Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
137.3 USD | -0.36% | -4.35% | +4.35% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.35% | 13.72B | |
+2.94% | 108B | |
+9.85% | 104B | |
+6.58% | 23.66B | |
-12.44% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.51% | 16.19B | |
+35.00% | 12.22B | |
-6.39% | 10.36B |
- Stock
- Equities
- Stock Neurocrine Biosciences, Inc. - Nasdaq
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Says US FDA Accepts Supplemental NDA for Valbenazine for Chorea Linked to Huntington Disease